Dr. rer. nat. Ina Becker

Lehrstuhl für Zellbiologie Department of Radiation Oncology

Prospective Assessment of the Inflammation Parameters in Blood Counts and Blood Serum as prognostic/predictive Parameters for Treatment with Immune Checkpoint-Inhibitors (2021) Schweizer C, Haderlein M, Schubert P, Zhou J, Semrau S, Rutzner S, Gostian AO, et al. Conference contribution The IMMO-LDRT01 Study - Analgesic and immunomodulatory Effects of LDRT in Patients with chronic degenerative and inflammatory Diseases (2021) Donaubauer AJ, Fröhlich B, Becker I, Weissmann T, Fietkau R, Ott O, Gaipl U, Frey B Conference contribution Detection of Human Cytomegalovirus (HCMV) in monocytic Cells of the peripheral Blood in Glioma Patients during Radio (chemo) Therapy (2021) Bäumler M, Becker I, Frey B, Pohn A, Winkler T, Fietkau R, Gaipl U Conference contribution The Early Landscape of Immune Cell Subsets in Metastatic NSCLC Patients Treated with Immune Checkpoint Inhibitors (2021) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Sun R, Ma H, et al. Conference contribution Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitors (2021) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Eckstein M, Sun R, et al. Journal article, Review article Reactivation of HCMV during RT of the brain results in critical illness and early mortality (2020) Frey B, Goerig N, Becker I, Donaubauer AJ, Korn K, Überla K, Schmidt M, et al. Conference contribution Development of a flow cytometry-based whole-blood prognostic immune signature in metastatic cancer patients treated with immune checkpoint inhibitors (2020) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Eckstein M, Sun R, et al. Conference contribution Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8 (2020) Hecht M, Gostian AO, Eckstein M, Rutzner S, Von Der Grün J, Illmer T, Hautmann MG, et al. Journal article Analysis of antioxidant Factors in Patients' Blood with chronic Degenerative and inflammatory Diseases in the Course of Low-Dose Radiotherapy (2020) Hehlgans S, Donaubauer AJ, Becker I, Frey B, Oppermann J, Ott O, Weissmann T, et al. Conference contribution Development of an immunological prognostic Signature in metastatic Patients who were treated with Immune Checkpoint Inhibitors as part of the ST-ICI Study (2020) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Sun R, Ma H, et al. Conference contribution